Thymosin beta 15A (TMSB15A) is a predictor of chemotherapy response in triple-negative breast cancer

por Darb-Esfahani, S, Kronenwett, R, von Minckwitz, G, Denkert, C, Gehrmann, M, Rody, A, Budczies, J, Brase, J C, Mehta, M K, Bojar, H, Ataseven, B, Karn, T, Weiss, E, Zahm, D M, Khandan, F, Dietel, M, Loibl, S
Publicado 2012

Characteristics of patients with brain metastases from human epidermal growth factor receptor 2-positive breast cancer: subanalysis of Brain Metastases in Breast Cancer Registry

por Laakmann, E., Witzel, I., Neunhöffer, T., Park-Simon, T.-W., Weide, R., Riecke, K., Polasik, A., Schmidt, M., Puppe, J., Mundhenke, C., Lübbe, K., Hesse, T., Thill, M., Zahm, D.-M., Denkert, C., Fehm, T., Nekljudova, V., Rey, J., Loibl, S., Müller, V.
Publicado 2022